136 related articles for article (PubMed ID: 26851596)
1. A role for Toll-like receptor 4 in the host response to the lung infection of Yersinia pseudotuberculosis in mice.
Choi JA; Jeong YJ; Kim JE; Kang MJ; Kim JC; Oh SM; Lee KB; Kim DH; Kim DJ; Park JH
Comp Immunol Microbiol Infect Dis; 2016 Feb; 44():54-60. PubMed ID: 26851596
[TBL] [Abstract][Full Text] [Related]
2. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
Fisher ML; Castillo C; Mecsas J
Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
[TBL] [Abstract][Full Text] [Related]
3. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.
Shen H; Gonzalez-Juarbe N; Blanchette K; Crimmins G; Bergman MA; Isberg RR; Orihuela CJ; Dube PH
Infect Genet Evol; 2016 Sep; 43():289-96. PubMed ID: 27268148
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
McPhee JB; Mena P; Zhang Y; Bliska JB
Infect Immun; 2012 Jul; 80(7):2519-27. PubMed ID: 22547545
[TBL] [Abstract][Full Text] [Related]
5. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.
Zhang Y; Bliska JB
Infect Immun; 2010 May; 78(5):2329-41. PubMed ID: 20231414
[TBL] [Abstract][Full Text] [Related]
6. Yersinia pseudotuberculosis adhesins regulate tissue-specific colonization and immune cell localization in a mouse model of systemic infection.
Hudson KJ; Bouton AH
Infect Immun; 2006 Nov; 74(11):6487-90. PubMed ID: 16920785
[TBL] [Abstract][Full Text] [Related]
7. The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis.
Bozue J; Mou S; Moody KL; Cote CK; Trevino S; Fritz D; Worsham P
Microb Pathog; 2011 Jun; 50(6):314-21. PubMed ID: 21320584
[TBL] [Abstract][Full Text] [Related]
8. Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.
Porte R; Van Maele L; Muñoz-Wolf N; Foligné B; Dumoutier L; Tabareau J; Cayet D; Gosset P; Jonckheere N; Van Seuningen I; Chabalgoity JA; Simonet M; Lamkanfi M; Renauld JC; Sirard JC; Carnoy C
Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27872237
[TBL] [Abstract][Full Text] [Related]
9. Yersinia pseudotuberculosis uses Ail and YadA to circumvent neutrophils by directing Yop translocation during lung infection.
Paczosa MK; Fisher ML; Maldonado-Arocho FJ; Mecsas J
Cell Microbiol; 2014 Feb; 16(2):247-68. PubMed ID: 24119087
[TBL] [Abstract][Full Text] [Related]
10. Morphogenesis of Experimental Infection Caused by Plasmid Variants of Yersinia pseudotuberculosis.
Somova LM; Drobot EI; Plekhova NG; Lyapun IN; Shubin FN
Bull Exp Biol Med; 2016 Dec; 162(2):264-268. PubMed ID: 27905039
[TBL] [Abstract][Full Text] [Related]
11.
Schachterle JK; Stewart RM; Schachterle MB; Calder JT; Kang H; Prince JT; Erickson DL
Front Cell Infect Microbiol; 2018; 8():323. PubMed ID: 30280093
[TBL] [Abstract][Full Text] [Related]
12. Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia.
Balada-Llasat JM; Panilaitis B; Kaplan D; Mecsas J
Vaccine; 2007 Feb; 25(8):1526-33. PubMed ID: 17194509
[TBL] [Abstract][Full Text] [Related]
13. Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes.
Crimmins GT; Mohammadi S; Green ER; Bergman MA; Isberg RR; Mecsas J
PLoS Pathog; 2012; 8(8):e1002828. PubMed ID: 22876175
[TBL] [Abstract][Full Text] [Related]
14. Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10.
Auerbuch V; Isberg RR
Infect Immun; 2007 Jul; 75(7):3561-70. PubMed ID: 17420232
[TBL] [Abstract][Full Text] [Related]
15. Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model.
Sing A; Tvardovskaia N; Rost D; Kirschning CJ; Wagner H; Heesemann J
Int J Med Microbiol; 2003 Nov; 293(5):341-8. PubMed ID: 14695062
[TBL] [Abstract][Full Text] [Related]
16. CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells.
Bergman MA; Loomis WP; Mecsas J; Starnbach MN; Isberg RR
PLoS Pathog; 2009 Sep; 5(9):e1000573. PubMed ID: 19730693
[TBL] [Abstract][Full Text] [Related]
17. Yersinia pseudotuberculosis YopH targets SKAP2-dependent and independent signaling pathways to block neutrophil antimicrobial mechanisms during infection.
Shaban L; Nguyen GT; Mecsas-Faxon BD; Swanson KD; Tan S; Mecsas J
PLoS Pathog; 2020 May; 16(5):e1008576. PubMed ID: 32392230
[TBL] [Abstract][Full Text] [Related]
18. Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model.
Kumar S; Balakrishna K; Agarwal GS; Merwyn S; Rai GP; Batra HV; Sardesai AA; Gowrishankar J
Antonie Van Leeuwenhoek; 2009 Jan; 95(1):91-100. PubMed ID: 18985430
[TBL] [Abstract][Full Text] [Related]
19. Compartmentalization of Th1/Th2 cytokine responses to experimental Yersinia pseudotuberculosis infection in cats.
Sukura A; Higgins J; Pedersen NC
Vet Immunol Immunopathol; 1998 Oct; 65(2-4):139-50. PubMed ID: 9839869
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cells Mediate Protection against Yersinia pseudotuberculosis in the Mesenteric Lymph Nodes.
Rosenheinrich M; Heine W; Schmühl CM; Pisano F; Dersch P
PLoS One; 2015; 10(8):e0136290. PubMed ID: 26296209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
